Imed Infinity Medical-Limited Partnership EBIT

Imed Infinity Medical-Limited Partnership (IMED.TA) currently reports a EBIT of $-550K as of June 2026. That compares with $-2.4M in the prior-year period — up 76.9% year over year. That is below the sector sector average of $2.5T. Use the charts on this page to explore Imed Infinity Medical-Limited Partnership's EBIT history and peer comparisons.

Imed Infinity Medical-Limited Partnership's EBIT increased from $-2.4M to $-550K — a 76.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Imed Infinity Medical-Limited Partnership's EBIT of $-550K is lower than the its sector sector average of $2.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Imed Infinity Medical-Limited Partnership reported $-550K in EBIT as of June 2026. That compares with $-2.4M in the prior-year period — up 76.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-550K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.5T. From there, open related valuation or income-statement pages for Imed Infinity Medical-Limited Partnership, and consider following IMED.TA for alerts when major investors trade the stock.